location:
  scaling:
    demographics|notdisadvantaged|sex_type|HML5|ppl:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HMM5|ppl:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFL5|ppl:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFM5|ppl:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HML5|ppl:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HMM5|ppl:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFL5|ppl:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFM5|ppl:
      field: override
      override: 1.0

    #Incarceration rates at initiation and throughout simulation
    demographics|notdisadvantaged|sex_type|HML5|incar|init:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HML5|incar|prob:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HMM5|incar|init:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HMM5|incar|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HML5|incar|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HML5|incar|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HMM5|incar|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HMM5|incar|prob:
      field: override
      override: 1.0

    #HIV Rate
    demographics|notdisadvantaged|sex_type|HML5|safe_sex|drug_type|None|hiv|init:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HMM5|safe_sex|drug_type|None|hiv|init:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFL5|safe_sex|drug_type|None|hiv|init:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFM5|safe_sex|drug_type|None|hiv|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HML5|safe_sex|drug_type|None|hiv|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HMM5|safe_sex|drug_type|None|hiv|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFL5|safe_sex|drug_type|None|hiv|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFM5|safe_sex|drug_type|None|hiv|init:
      field: override
      override: 1.0

    #Enrollment into ART at initiation (linked in 2011)
    demographics|notdisadvantaged|sex_type|HML5|safe_sex|drug_type|None|haart|init:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HMM5|safe_sex|drug_type|None|haart|init:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFL5|safe_sex|drug_type|None|haart|init:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFM5|safe_sex|drug_type|None|haart|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HML5|safe_sex|drug_type|None|haart|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HMM5|safe_sex|drug_type|None|haart|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFL5|safe_sex|drug_type|None|haart|init:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFM5|safe_sex|drug_type|None|haart|init:
      field: override
      override: 1.0

    #Enrollment into ART in 30 days (linked in 2012-2018)
    demographics|notdisadvantaged|sex_type|HML5|safe_sex|drug_type|None|haart|enroll|enroll_0|prob:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HMM5|safe_sex|drug_type|None|haart|enroll|enroll_0|prob:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFL5|safe_sex|drug_type|None|haart|enroll|enroll_0|prob:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFM5|safe_sex|drug_type|None|haart|enroll|enroll_0|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HML5|safe_sex|drug_type|None|haart|enroll|enroll_0|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HMM5|safe_sex|drug_type|None|haart|enroll|enroll_0|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFL5|safe_sex|drug_type|None|haart|enroll|enroll_0|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFM5|safe_sex|drug_type|None|haart|enroll|enroll_0|prob:
      field: override
      override: 1.0

    #Enrollment into ART after 30 days (receiving care 2012-2018)
    demographics|notdisadvantaged|sex_type|HML5|safe_sex|drug_type|None|haart|enroll|enroll_1|prob:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HMM5|safe_sex|drug_type|None|haart|enroll|enroll_1|prob:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFL5|safe_sex|drug_type|None|haart|enroll|enroll_1|prob:
      field: override
      override: 1.0
    demographics|notdisadvantaged|sex_type|HFM5|safe_sex|drug_type|None|haart|enroll|enroll_1|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HML5|safe_sex|drug_type|None|haart|enroll|enroll_1|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HMM5|safe_sex|drug_type|None|haart|enroll|enroll_1|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFL5|safe_sex|drug_type|None|haart|enroll|enroll_1|prob:
      field: override
      override: 1.0
    demographics|disadvantaged|sex_type|HFM5|safe_sex|drug_type|None|haart|enroll|enroll_1|prob:
      field: override
      override: 1.0